ICP-022

· Beijing InnoCare Pharma Tech Co., Ltd.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for ICP-022, covering 2022-07-06 to 2024-05-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ICP-022 in Patients With R/R DLBCL [Phase 2]